Prise en charge de l’asthme et de la BPCO en situation de pandémie de COVID-19 [Asthma and COPD management during the COVID-19 pandemic]
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_798F90DE5822
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Prise en charge de l’asthme et de la BPCO en situation de pandémie de COVID-19 [Asthma and COPD management during the COVID-19 pandemic]
Périodique
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
06/05/2020
Peer-reviewed
Oui
Volume
16
Numéro
692
Pages
933-938
Langue
français
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease.
Mots-clé
Asthma/complications, Asthma/therapy, Betacoronavirus, Coronavirus Infections/complications, Coronavirus Infections/epidemiology, Humans, Pandemics, Pneumonia, Viral/complications, Pneumonia, Viral/epidemiology, Pulmonary Disease, Chronic Obstructive/complications, Pulmonary Disease, Chronic Obstructive/therapy, Risk Factors
Pubmed
Création de la notice
16/06/2020 15:32
Dernière modification de la notice
19/08/2022 7:11